Orchid receives US FDA approval for cefuroxime injections
This article was originally published in Scrip
Executive Summary
Orchid Chemicals & Pharmaceuticalshas received US FDAapproval for three of its ANDAs for cefuroxime for injection, 750mg and 1.5g vials (infusion packs), 7.5g (pharmacy bulk pack) and 1.5g vial, generic versions of GlaxoSmithKline's broad-spectrum antibiotic agent for parenteral administration, Zinacef. Orchid now has 28 ANDA approvals.